Publicaciones en colaboración con investigadores/as de King's College London (10)

2024

  1. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

    Journal of Prevention of Alzheimer's Disease

2018

  1. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

2017

  1. Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status

    CNS Drugs, Vol. 31, Núm. 1, pp. 19-32

2015

  1. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease

    Aging Cell, Vol. 14, Núm. 1, pp. 122-129

2014

  1. Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with Aβ burden

    Neurochemistry International, Vol. 64, Núm. 1, pp. 29-36

  2. Serotonergic therapies for cognitive symptoms in alzheimer's disease: Rationale and current status

    Drugs, Vol. 74, Núm. 7, pp. 729-736

2013

  1. CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients

    Neurobiology of Aging, Vol. 34, Núm. 3, pp. 805-808

2010

  1. Altered NCAM expression associated with the cholinergic system in alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 20, Núm. 2, pp. 659-668

  2. Neurochemical basis for symptomatic treatment of Alzheimer's disease

    Neuropharmacology, Vol. 59, Núm. 4-5, pp. 221-229

1998

  1. Current neurotransmitter strategies in AD drug development

    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES